Page last updated: 2024-10-17

methylmalonic acid and Malignant Hypertension

methylmalonic acid has been researched along with Malignant Hypertension in 1 studies

Methylmalonic Acid: A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA.
methylmalonic acid : A dicarboxylic acid that is malonic acid in which one of the methylene hydrogens is substituted by a methyl group.

Research Excerpts

ExcerptRelevanceReference
"Malignant hypertension was diagnosed."1.40Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency. ( Benoist, JF; Cornec-Le Gall, E; De Parscau, L; Delmas, Y; Doucet, L; Fremeaux-Bacchi, V; Le Meur, Y; Ogier, H, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cornec-Le Gall, E1
Delmas, Y1
De Parscau, L1
Doucet, L1
Ogier, H1
Benoist, JF1
Fremeaux-Bacchi, V1
Le Meur, Y1

Other Studies

1 other study available for methylmalonic acid and Malignant Hypertension

ArticleYear
Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:1

    Topics: Adult; Amino Acid Metabolism, Inborn Errors; Antibodies, Monoclonal, Humanized; Betaine; Biopsy; Car

2014